Evoke Wealth, LLC Atai Life Sciences N.V. Transaction History
Evoke Wealth, LLC
- $4.37 Trillion
- Q2 2025
A detailed history of Evoke Wealth, LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Evoke Wealth, LLC holds 26,600 shares of ATAI stock, worth $153,748. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,600Holding current value
$153,748% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
117Shares Held
31.6MCall Options Held
494KPut Options Held
315K-
Ubs Group Ag7.7MShares$44.5 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$31.4 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$20.2 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$15.3 Million0.59% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$7.55 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $959M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...